openPR Logo
Press release

Pneumococcal Infections Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | GlaxoSmithKline, Gangagen, CanSino Biologics, Pfizer, Merck, EuBiologics, Astellas, Affinivax, Vaxcyte

11-29-2023 07:36 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Pneumococcal Infections Pipeline Analysis (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Pneumococcal Infections therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Pneumococcal Infections Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Pneumococcal Infections Therapeutics Market.

The report provides a detailed description of the Pneumococcal Infections drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Pneumococcal Infections Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/pneumococcal-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Pneumococcal Infections Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Pneumococcal Infections therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Pneumococcal Infections treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Pneumococcal Infections drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Pneumococcal Infections treatment market.

Learn More about the Clinical and Commercial Development Activities in the Pneumococcal Infections Therapeutics Domain @
https://www.delveinsight.com/report-store/pneumococcal-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Pneumococcal Infections Therapeutics Analysis
There are approx. 15+ key companies developing therapies for Pneumococcal infections. Currently, Affinivax is leading the therapeutics market with its Pneumococcal infections drug candidates in the most advanced stage of clinical development.

Pneumococcal Infections Companies in the Therapeutics Market Include:
GlaxoSmithKline, Gangagen, CanSino Biologics Inc., Pfizer, Merck Sharp & Dohme, EuBiologics, Beijing Zhifei Lvzhu Biopharmaceutical, SK Chemicals Co., Ltd., LG Life Sciences, Astellas Pharma, Affinivax, ImmunoBiology, Panacea Biotech, SutroVax, and Vaxcyte, and others.

Emerging and Marketed Pneumococcal Infections Therapies Covered in the Report Include:
ASP3772: Affinivax - ASP3772 is designed to elicit both B-cell (antibody) and T-cell immune protection against Streptococcus pneumoniae. ASP3772 includes 24 pneumococcal polysaccharides, as well as two conserved pneumococcal proteins. The results from the Phase II clinical trial demonstrated that ASP3772 was well tolerated.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for ASP3772 for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes included in ASP3772 in adults aged 50 years and older.

Get an in-depth Assessment of the Emerging Therapies and Pneumococcal Infections Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/pneumococcal-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Pneumococcal Infections Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Pneumococcal infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intranasal
• Intrathecal
• Intravenous
• Oral
• Oral/Intravenous
• Parenteral
• Subcutaneous
• Subcutaneous/Intramuscular
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Antisense oligonucleotide
• Gene therapy
• Hormones
• Neuropeptides
• Oligonucleotides
• Small Molecule
• Triglyceride

Request for Sample PDF to Understand More About the Pneumococcal Infections Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/pneumococcal-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Pneumococcal Infections Current Treatment Patterns
4. Pneumococcal Infections - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Pneumococcal Infections Late-Stage Products (Phase-III)
7. Pneumococcal Infections Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Pneumococcal Infections Discontinued Products
13. Pneumococcal Infections Product Profiles
14. Pneumococcal Infections Companies
15. Pneumococcal Infections Drugs
16. Dormant and Discontinued Products
17. Pneumococcal Infections Unmet Needs
18. Pneumococcal Infections Future Perspectives
19. Pneumococcal Infections Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/pneumococcal-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Tenosynovitis Market
https://www.delveinsight.com/report-store/tenosynovitis-market

Checkpoint Inhibitor Refractory Cancer Market
https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market

Encephalomyelitis Market
https://www.delveinsight.com/report-store/encephalomyelitis-market

FENEBRUTINIB Market
https://www.delveinsight.com/report-store/fenebrutinib-emerging-insight-and-market-forecast

Non-Muscle Invasive Bladder Cancer Market
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market

Nrg1 Fusion Cancer Pipeline Insight
https://www.delveinsight.com/report-store/nrg1-fusion-cancer-pipeline-insight

Acute Pyelonephritis Market
https://www.delveinsight.com/report-store/acute-pyelonephritis-market

Chronic Refractory Gout Market
https://www.delveinsight.com/report-store/chronic-refractory-gout-market

Complicated Urinary Tract Infections Market
https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market

Congestive Heart Failure (CHF) Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market

Glomerulonephritis Market
https://www.delveinsight.com/report-store/glomerulonephritis-market

Metastatic Uveal Melanoma (MUM) Market
https://www.delveinsight.com/report-store/metastatic-uveal-melanoma-mum-market

Musculoskeletal Pain Market
https://www.delveinsight.com/report-store/musculoskeletal-pain-market

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

Limb Girdle Muscular Dystrophy (LGMD) Market
https://www.delveinsight.com/report-store/limb-girdle-muscular-dystrophy-lgmd-market

Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market

Hemiplegia Market
https://www.delveinsight.com/report-store/hemiplegia-market

Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market

Hereditary Spastic Paraplegias Market
https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market

Amebiasis Market
https://www.delveinsight.com/report-store/amebiasis-market

Galactosemia Market
https://www.delveinsight.com/report-store/galactosemia-market

Generalized Pustular Psoriasis Market
https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market

Hepatic Impairment Market
https://www.delveinsight.com/report-store/hepatic-impairment-market

Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market

Amyloidosis Market
https://www.delveinsight.com/report-store/amyloidosis-market

BRAF-Mutant Metastatic Melanoma Market
https://www.delveinsight.com/report-store/braf-mutant-metastatic-melanoma-market

Candidemia Market
https://www.delveinsight.com/report-store/candidemia-market

Hepatitis D Market
https://www.delveinsight.com/report-store/hepatitis-d-market

Hyperkalemia Market
https://www.delveinsight.com/report-store/hyperkalemia-market

Vasomotor symptoms (Hot flashes/Night sweats) Market
https://www.delveinsight.com/report-store/vasomotor-symptoms-market

Balloon Valvuloplasty Device Market
https://www.delveinsight.com/report-store/balloon-valvuloplasty-market

Choroideremia Market
https://www.delveinsight.com/report-store/choroideremia-market

Chronic Hand Eczema Market
https://www.delveinsight.com/report-store/chronic-hand-eczema-market

Complex Regional Pain Syndrome Market
https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market

Diffuse Large B-cell Lymphoma Market
https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market

Hypersomnia Market
https://www.delveinsight.com/report-store/hypersomnia-market

Lamellar Ichthyosis (LI) Market
https://www.delveinsight.com/report-store/lamellar-ichthyosis-market

Ulcerative Colitis (UC) Market
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market

Vernal Keratoconjunctivitis Market
https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market-insight

Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market

Essential Thrombocythemia (ET) Market
https://www.delveinsight.com/report-store/essential-thrombocythemia-et-market-insights

Hepatorenal Syndrome Market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market

Pancreatic Ductal Carcinoma Market
https://www.delveinsight.com/report-store/pancreatic-ductal-carcinoma-market

Tenosynovial Giant Cell Tumors (TSGCTs) Market
https://www.delveinsight.com/report-store/tenosynovial-giant-cell-tumors-tsgcts-market

Trauma Fixation Devices Market
https://www.delveinsight.com/report-store/trauma-devices-market

Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market

Vulvar Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/vulvar-squamous-cell-carcinoma-market

Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumococcal Infections Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | GlaxoSmithKline, Gangagen, CanSino Biologics, Pfizer, Merck, EuBiologics, Astellas, Affinivax, Vaxcyte here

News-ID: 3309402 • Views:

More Releases from DelveInsight Business Research LLP

Fragile X Syndrome (FXS) Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Alcobra, Actinogen, Autifony, Healx, Roche, Lysogene, Marinus Pharmaceuticals, Neuren Pharma, NovaMentis, Novartis, Prilenia
Fragile X Syndrome (FXS) Pipeline Assessment Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Fragile X Syndrome therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Fragile X Syndrome (FXS) Pipeline
Acute Kidney Injury Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | AM-Pharma, Alexion, Alloksys, Aptabio Therapeutics, ArchBiopartners, Novartis, Ocelot Bio, River2Renal, Sentien
Acute Kidney Injury Pipeline Assessment Covering Clinical Trials, Emerging Thera …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Acute Kidney Injury therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Acute Kidney Injury Pipeline Insight"
Retinitis Pigmentosa Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | MeiraGTx, Aldeyra, SparingVision, ProQR Therapeutics, RetroSense, Endogena, Nacuity Pharmaceuticals, jCyte, Ocugen, Neurotech
Retinitis Pigmentosa Pipeline Assessment Covering Clinical Trials, Emerging Ther …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Retinitis Pigmentosa therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Retinitis Pigmentosa Pipeline Insight" report by
Schizophrenia Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Avanir, Boehringer Ingelheim, Cyclerion, Heptares, Medicell, Merck, Otsuka, Recognify, PsychoGenics, SyneuRx, Takeda, Valentech, Vigonvita
Schizophrenia Pipeline Assessment Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 70+ key pharma and biotech companies are working on 70+ pipeline drugs in the Schizophrenia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Schizophrenia Pipeline Insight" report by DelveInsight provides

All 5 Releases


More Releases for Pneumococcal

Global To Invigorate The Intravenous Pneumococcal Vaccines Market
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine. The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than two years of age, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. The CDC recommends pneumococcal polysaccharide vaccine for all
Pneumococcal Vaccines Market Demands and Gross Margin 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
Pneumococcal and Meningococcal Vaccines Market Analysis by Industry 2020
The Pneumococcal & Meningococcal Vaccines Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and New innovations. The report contains a granular analysis of the present industry situations, market demands, reveal
Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p …
Latest Survey on Pneumococcal Vaccine Market: The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It also
Pneumococcal Vaccines Market | North America Dominated the Global Market
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Global Pneumococcal Vaccine Industry Market Analysis & Forecast 2018-2023
Global Pneumococcal Vaccine Industry Market results in aggravation noticeable all around sacs (known as alveoli) of the lungs, which brings about filling the alveoli with liquid (discharge cells), accordingly causing breathing issues. Pneumococcal Vaccine illness is regular in youthful youngsters, however more established grown-ups are at most serious danger of genuine pneumococcal diseases and even demise. Get sample copy of report: https://www.marketdensity.com/contact?ref=Sample&reportid=4396 Table of Contents 1 Industry Overview 1.1 Pneumococcal Vaccine Industry 1.1.1